Human APOA4 activation kit by CRISPRa

CAT#: GA100238

APOA4 CRISPRa kit - CRISPR gene activation of human apolipoprotein A4



  See Other Versions

CNY 12,255.00


货期*
4周

规格
    • 1 kit

Product images

经常一起买 (3)
Rabbit Polyclonal Anti-APOA4 Antibody
    • 100 ul

CNY 1,999.00
CNY 3,280.00


APOA4 (Myc-DDK-tagged)-Human apolipoprotein A-IV (APOA4)
    • 10 ug

CNY 3,656.00
CNY 3,990.00


ApoA4 Mouse monoclonal Antibody
    • 100 ul

CNY 1,999.00
CNY 3,280.00

Specifications

Product Data
Format 3 gRNAs (5ug each), 1 scramble ctrl (10ug) and 1 enhancer vector (10ug)
Symbol APOA4
Locus ID 337
Kit Components

GA100238G1, APOA4 gRNA vector 1 in pCas-Guide-GFP-CRISPRa

GA100238G2, APOA4 gRNA vector 2 in pCas-Guide-GFP-CRISPRa

GA100238G3, APOA4 gRNA vector 3 in pCas-Guide-GFP-CRISPRa

1 CRISPRa-Enhancer vector, SKU GE100056

1 CRISPRa scramble vector, SKU GE100077

Disclaimer These products are manufactured and supplied by OriGene under license from ERS. The kit is designed based on the best knowledge of CRISPRa SAM technology. The efficiency of the activation can be affected by many factors, including nucleosome occupancy status, chromatin structure and the gene expression level of the target, etc.
Reference Data
RefSeq NM_000482
Synonyms MGC142154; MGC142156
Summary Apoliprotein (apo) A-IV gene contains 3 exons separated by two introns. A sequence polymorphism has been identified in the 3'UTR of the third exon. The primary translation product is a 396-residue preprotein which after proteolytic processing is secreted its primary site of synthesis, the intestine, in association with chylomicron particles. Although its precise function is not known, apo A-IV is a potent activator of lecithin-cholesterol acyltransferase in vitro. [provided by RefSeq, Jul 2008]
*Delivery time may vary from web posted schedule. Occasional delays may occur due to unforeseen complexities in the preparation of your product. International customers may expect an additional 1-2 weeks in shipping.

Documents

Other Versions

Customer Reviews 
Loading...